GW&K Investment Management LLC Purchases 4,581 Shares of UnitedHealth Group Inc (NYSE:UNH)

GW&K Investment Management LLC raised its position in UnitedHealth Group Inc (NYSE:UNH) by 1.9% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 243,407 shares of the healthcare conglomerate’s stock after purchasing an additional 4,581 shares during the period. UnitedHealth Group makes up about 0.7% of GW&K Investment Management LLC’s investment portfolio, making the stock its 27th biggest holding. GW&K Investment Management LLC’s holdings in UnitedHealth Group were worth $52,897,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Northern Trust Corp boosted its holdings in shares of UnitedHealth Group by 0.4% in the second quarter. Northern Trust Corp now owns 12,111,540 shares of the healthcare conglomerate’s stock valued at $2,955,336,000 after buying an additional 53,710 shares during the period. Nuveen Asset Management LLC boosted its holdings in shares of UnitedHealth Group by 1,354.6% in the second quarter. Nuveen Asset Management LLC now owns 8,540,562 shares of the healthcare conglomerate’s stock valued at $2,083,983,000 after buying an additional 7,953,416 shares during the period. Janus Henderson Group PLC boosted its holdings in shares of UnitedHealth Group by 16.7% in the second quarter. Janus Henderson Group PLC now owns 6,448,289 shares of the healthcare conglomerate’s stock valued at $1,573,438,000 after buying an additional 922,290 shares during the period. Viking Global Investors LP boosted its holdings in shares of UnitedHealth Group by 28.6% in the second quarter. Viking Global Investors LP now owns 4,812,185 shares of the healthcare conglomerate’s stock valued at $1,174,221,000 after buying an additional 1,071,149 shares during the period. Finally, Sanders Capital LLC boosted its holdings in shares of UnitedHealth Group by 50.2% in the second quarter. Sanders Capital LLC now owns 4,626,666 shares of the healthcare conglomerate’s stock valued at $1,255,689,000 after buying an additional 1,546,140 shares during the period. 85.66% of the stock is owned by hedge funds and other institutional investors.

UNH has been the subject of several research analyst reports. Cleveland Research reiterated a “buy” rating on shares of UnitedHealth Group in a report on Monday, July 15th. Deutsche Bank initiated coverage on shares of UnitedHealth Group in a report on Thursday, September 12th. They issued a “hold” rating and a $263.00 price target for the company. BMO Capital Markets cut shares of UnitedHealth Group from an “outperform” rating to a “market perform” rating and reduced their price target for the company from $292.00 to $249.00 in a report on Monday, September 30th. Jefferies Financial Group cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating and reduced their target price for the stock from $300.00 to $235.00 in a report on Thursday, October 10th. Finally, Credit Suisse Group set a $293.00 target price on shares of UnitedHealth Group and gave the stock a “buy” rating in a report on Thursday, August 29th. Five investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $283.84.

UNH traded up $0.51 during trading hours on Friday, hitting $256.97. 2,161,274 shares of the company’s stock were exchanged, compared to its average volume of 4,544,972. UnitedHealth Group Inc has a 1-year low of $208.07 and a 1-year high of $287.94. The stock’s 50-day moving average is $234.76 and its two-hundred day moving average is $241.05. The stock has a market cap of $237.20 billion, a price-to-earnings ratio of 19.95, a PEG ratio of 1.33 and a beta of 0.61. The company has a quick ratio of 0.67, a current ratio of 0.70 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $3.88 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.75 by $0.13. The business had revenue of $60.35 billion during the quarter, compared to analysts’ expectations of $59.84 billion. UnitedHealth Group had a net margin of 5.57% and a return on equity of 25.30%. The firm’s revenue was up 6.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $3.41 earnings per share. On average, equities research analysts anticipate that UnitedHealth Group Inc will post 14.96 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be paid a $1.08 dividend. This represents a $4.32 dividend on an annualized basis and a yield of 1.68%. UnitedHealth Group’s dividend payout ratio is currently 33.54%.

In other UnitedHealth Group news, Director Richard T. Burke sold 2,000 shares of the stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $231.50, for a total value of $463,000.00. Following the completion of the sale, the director now owns 187,979 shares in the company, valued at $43,517,138.50. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CAO Thomas E. Roos sold 1,177 shares of the stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $255.04, for a total transaction of $300,182.08. Following the completion of the sale, the chief accounting officer now owns 21,687 shares of the company’s stock, valued at approximately $5,531,052.48. The disclosure for this sale can be found here. In the last quarter, insiders sold 33,177 shares of company stock valued at $7,842,582. Corporate insiders own 0.87% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: What is diluted earnings per share (Diluted EPS)?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.